Alongside E coli, which can cause diarrhoea, stomach cramps and a fever, the bacteria Salmonella enterica and Citrobacter koseri – which can lead to meningitis and brain abscesses – were also ...

coli and Citrobacter koseri are a leading cause of death among patients with inflammatory bowel diseases, which affect millions of people around the world. These bacteria are known to enter the ...

Host cells activate cell death pathways in response to bacterial manipulation of innate immune signalling, but the molecular mechanisms underlying this interplay are not fully understood. This study ...

The U.S. Food and Drug Administration has granted approval to a new antibiotic to treat urinary tract infections in women and ...

A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...

Blujepa, which is made by the British pharmaceutical company GSK plc, is approved for the treatment of women and children ...

Bacterial genetics is the study of the mechanisms ... and enable the quantification of gene fitness during in vivo Citrobacter rodentium infection. Organisms display non-uniform transcriptional ...

The drug is a needed new option for treating uncomplicated UTIs, a common infection that’s becoming harder to treat as rates ...

Additionally, the risk of bacterial resistance is low ... Klebsiella pneumoniae, Citrobacter freundii complex, Staphylococcus saprophyticus and Enterococcus faecalis. The FDA approval is supported ...

is approved for the treatment of women and children over the age of 12 with uncomplicated UTIs caused by bacteria including E. coli, Klebsiella pneumoniae, Citrobacter freundii complex ...